Polyunsaturated Fatty Acids (PUFAs) Market

By Product Type;

Omega-3 Fatty Acids and Omega-6 Fatty Acids

By Source;

Marine, Plant, Chia Seed Oil, Flax Seed Oil and Others

By Application;

Dietary Supplements, Infant Formula, Pharmaceuticals, Food & Beverages and Animal Food & Feed

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn880683845 Published Date: September, 2025 Updated Date: November, 2025

Polyunsaturated Fatty Acids (PUFAs) Market Overview

Polyunsaturated Fatty Acids (PUFAs) Market (USD Million)

Polyunsaturated Fatty Acids (PUFAs) Market was valued at USD 9,498.81 million in the year 2024. The size of this market is expected to increase to USD 19,350.97 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.7%.


Polyunsaturated Fatty Acids (PUFAs) Market

*Market size in USD million

CAGR 10.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)10.7 %
Market Size (2024)USD 9,498.81 Million
Market Size (2031)USD 19,350.97 Million
Market ConcentrationLow
Report Pages317
9,498.81
2024
19,350.97
2031

Major Players

  • Koninklijke DSM N.V.
  • BASF SE
  • Croda International PLC
  • Enzymotec Ltd.
  • Omega Protein Corporation
  • Aker BioMarine AS
  • Polaris Nutritional Lipids
  • FMC Corporation
  • Cargill
  • GlaxoSmithKline Plc.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Polyunsaturated Fatty Acids (PUFAs) Market

Fragmented - Highly competitive market without dominant players


The Polyunsaturated Fatty Acids (PUFAs) Market is experiencing strong momentum, driven by rising demand for nutritional supplements and functional foods. More than 55% of consumers now prioritize PUFA-rich products to support heart health, cognitive function, and overall wellness. Their applications across dietary supplements, pharmaceuticals, and food fortification are making PUFAs an essential component of modern health solutions.

Expanding Nutraceutical and Food Applications
A significant portion of growth stems from the increasing use of PUFAs in nutraceuticals and fortified foods. Close to 48% of dietary supplement formulations now include omega-3 and omega-6 fatty acids, highlighting their importance in preventive healthcare. The trend toward healthier lifestyles and consumer awareness of nutritional benefits is expanding PUFA adoption in everyday diets.

Technological Advancements in Production
Advances in biotechnology and extraction methods are boosting supply efficiency and purity levels. Roughly 40% of new PUFA products are derived from algae-based and plant-based sources, catering to vegan and sustainability-conscious consumers. These innovations are helping manufacturers improve cost-efficiency while aligning with clean-label and eco-friendly product trends.

Growing Awareness and Preventive Health Trends
The rising focus on preventive healthcare is significantly expanding PUFA consumption. Over 50% of consumers in developed regions actively choose PUFA-enriched supplements to reduce lifestyle-related disease risks. This rising awareness, combined with supportive health campaigns and research-backed evidence, continues to fuel steady market expansion.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Source
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Polyunsaturated Fatty Acids (PUFAs) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Awareness of Heart Health

        2. Growing Application in Functional Foods

        3. Expansion in Pharmaceutical Applications

      2. Restraints
        1. Environmental Concerns in Fish Oil Sourcing

        2. Price Volatility of Raw Materials

        3. Regulatory Challenges and Compliance

      3. Opportunities
        1. Advancements in Extraction and Purification Technologies

        2. Expanding Applications in Functional Foods and Beverages

        3. Focus on Plant-Based Omega-3 Sources

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Polyunsaturated Fatty Acids (PUFAs) Market, By Product Type, 2021 - 2031 (USD Million)
      1. Omega-3 Fatty Acids
      2. Omega-6 Fatty Acids
    2. Polyunsaturated Fatty Acids (PUFAs) Market, By Source, 2021 - 2031 (USD Million)
      1. Marine
      2. Plant
      3. Chia Seed Oil
      4. Flax Seed Oil
      5. Others
    3. Polyunsaturated Fatty Acids (PUFAs) Market, By Application, 2021 - 2031 (USD Million)
      1. Dietary Supplements
      2. Infant Formula
      3. Pharmaceuticals
      4. Food & Beverages
      5. Animal Food & Feed
    4. Polyunsaturated Fatty Acids (PUFAs) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. BASF SE
      2. Cargill, Incorporated
      3. Koninklijke DSM N.V.
      4. Croda International PLC
      5. Omega Protein Corporation
      6. Aker BioMarine AS
      7. Polaris Nutritional Lipids
      8. FMC Corporation
      9. GlaxoSmithKline plc
      10. Enzymotec Ltd
      11. Corbion N.V.
      12. Arista Industries Inc.
      13. KD Pharma Group
      14. Novotech Nutraceuticals
      15. EPAX Norway AS
  7. Analyst Views
  8. Future Outlook of the Market